Baptiste Abbar

Sorbonne Université

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Joshua Levenson

University of Pittsburgh Medical Center

UNITED STATES

View details

Han Zhu

Stanford University School of Medicine

UNITED STATES

View details

Yuichi Tamura

International University of Health and Welfare Mita Hospital

JAPAN

View details

Juan Qin

UCSF Cardiovascular Research Institute

UNITED STATES

View details

LEONARD LOUIS Sarah

Sorbonne Université

FRANCE

View details

Joe-Elie Salem

Full Professor

Assistance Publique - Hôpitaux de Paris

FRANCE

View details

jean philippe spano

Professor

FRANCE

View details

Adrien PROCUREUR

Assistant Professor

Sorbonne Université

FRANCE

View details

jacques cadranel

Head of Department

Sorbonne Université

FRANCE

View details

ryota morimoto

Nagoya University Hospital

JAPAN

View details

Marine Baron

FRANCE

View details

Anne-Sophie HAMY

Institut Curie

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Baptiste Abbar

Research Interests

Explore related searches

Contact this professor

Articles (18)

Comedications Associated with Immune‐Related Adverse Events from Immune‐Checkpoint Inhibitors

Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC

Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective

Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis

FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study

Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

Vinorelbine thiotepa in metastatic breast cancer: a large real-life retrospective study

Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells.

Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma

Grade 3–4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study

Reversible Tumor Progression Induced by a Dexamethasone Course for Severe COVID-19 during Immune Checkpoint Inhibitor Treatment

Androgens, QT, sex and ventricular repolarization–a double-edged sword: A case series

Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis

Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept

Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer

18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging for the diagnosis of immune checkpoint inhibitor-associated myocarditis

Collaborators (12)

Joshua Levenson

Han Zhu

Yuichi Tamura

Juan Qin

LEONARD LOUIS Sarah

Joe-Elie Salem

jean philippe spano

Adrien PROCUREUR

jacques cadranel

ryota morimoto

Marine Baron

Anne-Sophie HAMY

Make your next move.